Fuhrman Alan received 951 Tyra Biosciences shares at $9.13 each, leaving him with 37,115 shares. The transaction represented about 2.6% of his resulting holding, giving investors the reported size of the award and the executive’s post-transaction position.
Key Highlights
- Fuhrman Alan’s Tyra Biosciences award was priced at $9.13 per share.
- The transaction left the executive with 37,115 Tyra Biosciences shares.
- SEC transaction code A classifies the event as an award or grant.
Fuhrman Alan received 951 shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) at $9.13 each on 15 September 2026, leaving him with 37,115 shares. The transaction represented about 2.6% of his resulting holding. Alan is Tyra Biosciences’ Chief Financial Officer.
Award Adds 951 Tyra Biosciences Shares
His ownership after the transaction stood at 37,115 shares. The entry was dated 15 September 2026. The award involved Fuhrman Alan directly.
FAQs
Q: What did Fuhrman Alan receive from Tyra Biosciences?
A: Tyra Biosciences awarded Fuhrman Alan 951 shares at $9.13 each on 15 September 2026.
Q: How many Tyra Biosciences shares did Fuhrman Alan own afterward?
A: Fuhrman Alan owned 37,115 Tyra Biosciences shares after the transaction. He was identified as the company’s Chief Financial Officer.
Q: What percentage of Fuhrman Alan’s holding did the transaction represent?
A: The Tyra Biosciences transaction represented about 2.6% of Fuhrman Alan’s resulting shares holding. The percentage refers to the position reported after the award.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.